ShockWave Medical, Inc. (SWAV)

$198.62

+7.45 (+3.90%)
Rating:
Recommendation:
-
Symbol SWAV
Price $198.62
Beta 1.485
Volume Avg. 0.65M
Market Cap 7.109B
Shares () -
52 Week Range 113.36-249.73
1y Target Est -
DCF Unlevered SWAV DCF ->
DCF Levered SWAV LDCF ->
ROE 12.36% Buy
ROA 7.78% Neutral
Operating Margin -
Debt / Equity 39.09% Neutral
P/E 239.30 Strong Buy
P/B 26.39 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SWAV news


Mr. Douglas Godshall
Healthcare
Medical Devices
NASDAQ Global Select

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.